BRAF V600E and survival benefit of anti-EGFR monoclonal antibody (mAb) therapy for metastatic colorectal cancer (mCRC): A meta-analysis.

被引：0
|
作者：
Sorich, Michael
Rowland, Andrew
Dias, Mafalda
McKinnon, Ross Allan
Kichenadasse, Ganessan
Wiese, Michael
Karapetis, Christos Stelios
机构：
[1] Flinders Univ S Australia, Adelaide, SA 5001, Australia
[2] Flinders Univ S Australia, Flinders Med Ctr, Adelaide, SA 5001, Australia
[3] Univ S Australia, Adelaide, SA 5001, Australia
[4] Flinders Univ S Australia, Flinders Ctr Innovat Canc, Adelaide, SA 5001, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e14605
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14605
引用
收藏
页数：1
相关论文
共 50 条
  • [41] BRAF V600E confers resistance to cetuximab or panitumumab metastatic colorectal cancer
    Di Nicolantonio, F.
    Martini, M.
    Molinari, F.
    Bianchi, A. Sartore
    Arena, S.
    Saletti, P.
    Mazzucchelli, L.
    Frattini, M.
    Siena, S.
    Bardelli, A.
    EJC SUPPLEMENTS, 2008, 6 (12): : 81 - 81
  • [42] Targeting BRAF V600E in metastatic colorectal cancer: where are we today?
    Guerrero, Rodrigo Motta
    Labajos, Veronica Arnao
    Ballena, Sophia Lozano
    Macha, Carlos Aliaga
    Lezama, Miguel Sotelo
    Roman, Cristian Pacheco
    Beltran, Paola Montenegro
    Torrejon, Alejandro Figueroa
    ECANCERMEDICALSCIENCE, 2022, 16
  • [43] BRAF V600E Mutation Analysis in Metastatic Colorectal Carcinoma: MSKCC Experience
    Nafa, K.
    Arcila, M. E.
    Saltz, L. B.
    Ladanyi, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 665 - 665
  • [44] Rechallenge with Anti-EGFR Therapy in Metastatic Colorectal Cancer (mCRC): Results from South Australia mCRC Registry
    Chong, Li Chia
    Hardingham, Jennifer E.
    Townsend, Amanda R.
    Piantadosi, Cynthia
    Rico, Gonzalo Tapia
    Karapetis, Chris
    Padbury, Rob
    Maddern, Guy
    Roy, Amitesh
    Price, Timothy J.
    TARGETED ONCOLOGY, 2020, 15 (06) : 751 - 757
  • [45] Rechallenge with Anti-EGFR Therapy in Metastatic Colorectal Cancer (mCRC): Results from South Australia mCRC Registry
    Li Chia Chong
    Jennifer E. Hardingham
    Amanda R. Townsend
    Cynthia Piantadosi
    Gonzalo Tapia Rico
    Chris Karapetis
    Rob Padbury
    Guy Maddern
    Amitesh Roy
    Timothy J. Price
    Targeted Oncology, 2020, 15 : 751 - 757
  • [46] Clinical prognostic score of BRAF V600E mutated (BM) metastatic colorectal cancer (mCRC): Results from the "BRAF, BeCool" platform.
    Intini, Rossana
    Loupakis, Fotios
    Cremolini, Chiara
    Sartore-Bianchi, Andrea
    Pietrantonio, Filippo
    Pella, Nicoletta
    Santini, Daniele
    Rimassa, Lorenza
    Formica, Vincenzo
    Calvetti, Lorenzo
    Salvatore, Lisa
    Antonuzzo, Lorenzo
    De Luca, Emmanuele
    Morano, Federica
    Tosi, Federica
    Moretto, Roberto
    Fassan, Matteo
    De Maglio, Giovanna
    Zagonel, Vittorina
    Di Maio, Massimo
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [47] The pathologist's involvement in anti-EGFR antibody therapy in metastatic colorectal cancer
    Sacoun, Esther
    ANNALES DE PATHOLOGIE, 2010, 30 (04) : VII - X
  • [48] A method to assess KRAS/BRAF genotype in patients with metastatic colorectal cancer (mCRC) elligible for anti-EGFR therapies
    Lamy, A.
    Labourier, E.
    Prigneau, O.
    Di Fiore, F.
    Sesbouea, R.
    Sabourin, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [49] Efficacy and circulating tumor DNA (ctDNA) analysis of the BRAF inhibitor dabrafenib (D), MEK inhibitor trametinib (T), and anti-EGFR antibody panitumumab (P) in patients (pts) with BRAF V600E-mutated (BRAFm) metastatic colorectal cancer (mCRC)
    Corcoran, R. B.
    Andre, T.
    Yoshino, T.
    Bendell, J. C.
    Atreya, C. E.
    Schellens, J. H. M.
    Ducreux, M. P.
    McRee, A.
    Siena, S.
    Middleton, G.
    Gordon, M.
    Humblet, Y.
    Muro, K.
    Elez, E.
    Yaeger, R.
    Sidhu, R.
    Squires, M.
    Jaeger, S.
    Rangwala, F.
    Van Cutsem, E.
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] Activity of EGFR antibody in non-V600 BRAF mutant metastatic colorectal cancer
    Wang, Y.
    Jones, J. C.
    Kipp, B. R.
    Grothey, A.
    ANNALS OF ONCOLOGY, 2019, 30 (01) : 147 - 149
12345